A 12-week individualized training program significantly improved six-minute walking distance in children with congenital heart disease (529.6 vs. 467.7 m, p<0.001).
RCT (n=31)
randomly divided
Does an individualized 12-week training exercise program improve exercise tolerance and cardiorespiratory responses in children with congenital heart disease?
A 12-week individualized training program significantly improves walking distance and cardiorespiratory responses in children with congenital heart disease, and the 6-minute walk test is a reliable tool for assessment.
Absolute Event Rate: 529.6% vs 467.7%
p-value: p=<0.001
This study assessed the exercise tolerance and the cardiorespiratory responses to a training program by the six-minute walk test (6'WT) in children with congenital heart disease (CHD). Seventeen cardiac and 14 healthy children performed maximal cardiopulmonary exercise test (CPET) and 6'WT. Reliability of 6'WT was assessed in all subjects (test-retest) by Bland-Altman plots. Cardiac subjects were randomly divided in training (T-CHD) and control groups (C-CHD). T-CHD underwent an individualized training exercise at the ventilatory threshold (VT) intensity during 12 weeks. We found that the 6'WT is a reliable and reproducible test. CHD children walked a lower distance than healthy children before training (472.5 +/- 18.1 vs. 548.8 +/- 7.7 m, respectively, p 0.05) at peak exercise and significantly at ventilatory threshold level (p < 0.05) in T-CHD. Significant relationships between WD and VO2max as well as VO2 at VT were founded (p < 0.05). We concluded that the 6'WT is a useful and reliable tool in the assessment and follow-up of functional capacity during rehabilitation program in children with CHD.
Moalla et al. (Thu,) conducted a rct in congenital heart disease (CHD) (n=31). Individualized training exercise at the ventilatory threshold (VT) intensity vs. Control group (C-CHD) was evaluated on Walking distance (WD) in the six-minute walk test (p=<0.001). A 12-week individualized training program significantly improved six-minute walking distance in children with congenital heart disease (529.6 vs. 467.7 m, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: